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Abstract 
Background: Malaria control today is threatened by widespread insecticide resistance in vector populations. The 
World Health Organization (WHO) recommends the use of a mixture of unrelated insecticides for indoor residual 
spraying (IRS) and long-lasting insecticidal nets (LNs) or as a combination of interventions for improved vector control 
and insecticide resistance management. Studies investigating the efficacy of these different strategies are necessary.
Methods: The efficacy of  Interceptor® G2 LN, a newly developed LN treated with a mixture of chlorfenapyr (a pyr-
role) and alpha-cypermethrin (a pyrethroid), was compared to a combined chlorfenapyr IRS and  Interceptor® LN 
(a standard alpha-cypermethrin LN) intervention in experimental huts in Cove Southern Benin, against wild, free-
flying, pyrethroid-resistant Anopheles gambiae s.l. A direct comparison was also made with a pyrethroid-only net 
 (Interceptor® LN) alone and chorfenapyr IRS alone.
Results: WHO resistance bioassays performed during the trial demonstrated a pyrethroid resistance frequency of 
>90% in the wild An. gambiae s.l. from the Cove hut site. Mortality in the control (untreated net) hut was 5%. Mortality 
with  Interceptor® LN (24%) was lower than with chlorfenapyr IRS alone (59%, P < 0.001). The combined  Interceptor® 
LN and chlorfenapyr IRS intervention and the mixture net  (Interceptor® G2 LN) provided significantly higher mortality 
rates (73 and 76%, respectively) and these did not differ significantly between both treatments (P = 0.15). Intercep-
tor LN induced 46% blood-feeding inhibition compared to the control untreated net, while chlorfenapyr IRS alone 
provided none. Both mixture/combination strategies also induced substantial levels of blood-feeding inhibition (38% 
with combined interventions and 30% with  Interceptor® G2 LN). A similar trend of improved mortality of pyrethroid-
resistant An. gambiae s.l. from Cove was observed with  Interceptor® G2 LN (79%) compared to Interceptor LN (42%, 
P < 0.001) in WHO tunnel tests.
Conclusion: The use of chlorfenapyr and alpha-cypermethrin together as a mixture on nets  (Interceptor® G2 LN) or a 
combined chlorfenapyr IRS and pyrethroid LN intervention provides improved control of pyrethroid-resistant malaria 
vectors by inducing significantly higher levels of mortality through the chlorfenapyr component and providing per-
sonal protection through the pyrethroid component. Both strategies are comparable in their potential to improve the 
control of malaria transmitted by pyrethroid resistant mosquito vectors.
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Background
Indoor residual spraying (IRS) and long-lasting insecti-
cidal nets (LNs) have contributed immensely to recent 
reductions in malaria burden [1]. The sustainability of 
this impact is however threatened by widespread resist-
ance to the insecticides delivered through these interven-
tions, especially pyrethroids [2]. Modelling studies have 
suggested that if nothing is done about insecticide resist-
ance, the recent fragile gains in malaria control could be 
reversed, thus calling for urgent concerted efforts to miti-
gate these threats [2].
Pyrethroids are currently the only insecticide used on 
WHOPES-recommended LNs owing to their efficacy, 
safety, low cost, and excito-repellent effect on mos-
quitoes, an insecticidal property which is essential for 
preventing mosquito biting [3]. The identification of 
alternative insecticides for treating LNs has been very 
challenging because most non-pyrethroid insecticides 
lack this excito-repellent effect which is responsible for 
providing personal protection to net users and increas-
ing acceptability of the intervention [4, 5]. As an interim 
solution, novel non-pyrethroid insecticides being devel-
oped for vector control can be mixed with pyrethroids on 
bed nets or deployed as IRS in combination with pyre-
throid LNs. By presenting the non-pyrethroid insecti-
cide together with a pyrethroid, whether as a mixture 
on the net or a combined intervention, there is potential 
to maintain personal protection through the pyrethroid 
component while achieving high mosquito mortality 
rates through the non-pyrethroid. The use of unrelated 
insecticides in mixtures or as a combined intervention 
for malaria vector control is recommended by the Global 
Plan for Insecticide Resistance Management (GPIRM) 
because it also has the potential to preserve insecticide 
susceptibility in areas where resistance to both active 
ingredients is still rare [2, 6].
With increased funding for vector control, espe-
cially from the US President’s Malaria Initiative (PMI), 
some vector control programmes have deployed non-
pyrethroid IRS together with pyrethroid LNs with the 
objective of improving malaria control [7, 8]. While the 
impact of this approach has been controversial, some 
studies have shown that improved vector control is pos-
sible but may depend on the insecticide being used for 
IRS and the resistance status and behaviour of the tar-
get vector population [9, 10]. By using mixtures of non-
pyrethroid insecticides with pyrethroids on LNs it may 
also be possible to achieve improved vector control with 
a single intervention since the underlying concept is simi-
lar to the combined non-pyrethroid IRS and pyrethroid 
LN intervention. To provide some guidance to product 
development companies involved in the development 
of novel public health insecticides and vector control 
programmes, studies comparing the efficacy of both 
approaches are necessary.
Chlorfenapyr is a novel pyrrole insecticide, which has 
shown potential to significantly improve the control of 
pyrethroid resistant malaria vectors [4, 11–14]. It shows 
no cross-resistance to current public health insecticides 
and has thus been evaluated for IRS and mosquito nets 
[14]. However, because chlorfenapyr lacks excito-repel-
lency, it confers very limited personal protection to the 
user when applied alone [12]. Chlorfenapyr can there-
fore be mixed with pyrethroids on LNs and for IRS or 
deployed as IRS in combination with pyrethroid LNs 
with the aim of improving mortality while providing per-
sonal protection through the excito-repellent property of 
the pyrethroid. In this study, the efficacy of  Interceptor® 
G2 LN, a newly developed mixture LN treated with 
chlorfenapyr and alpha-cypermethrin (a pyrethroid) 
was compared to a combined chlorfenapyr IRS and 
pyrethroid-only LN  (Interceptor® LN) intervention in 
experimental huts against pyrethroid-resistant Anopheles 
gambiae sensu lato (s.l.) in Cove, Southern Benin.
Methods
Study site and experimental huts
The study was performed in an experimental hut sta-
tion situated at the centre of a large rice-growing field in 
Cove, Southern Benin. The rice paddies provide exten-
sive breeding sites for An. gambiae s.l. throughout the 
year. The rainy season extends from March to October 
and the dry season from November to February. The trial 
was performed between June and September 2015 in five 
experimental huts of the West African design. Prelimi-
nary studies revealed that the huts were equally attractive 
to mosquitoes. The experimental huts are built on con-
crete plinths surrounded by water-filled moats to prevent 
entry of scavenging ants, and have veranda traps to cap-
ture the exiting mosquitoes. The walls are made of brick 
plastered with cement on the inside, with a corrugated 
iron roof. The huts have a ceiling of palm thatch and 
four window slits (1-cm gap) on the walls through which 
mosquitoes enter. The local vector population in Cove is 
resistant to pyrethroids and DDT and consists of a mix-
ture of Anopheles coluzzii and An. gambiae sensu stricto 
(s.s.), with the latter occurring at lower proportions 
(23%) and only in the dry season [15]. Molecular analy-
sis revealed a L1014F kdr allele frequency of 89%. Micro-
array studies performed a year before the study also 
found CYP6P3, a P450 validated as an efficient metabo-
lizer of pyrethroids [16] to be overexpressed in Cove [15].
WHO susceptibility bioassays
To determine the frequency of resistance to pyrethroids 
and organochlorines in the wild An. gambiae Cove vector 
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population during the trial, mosquitoes that emerged 
from larvae collected from breeding sites at the experi-
mental hut station were tested in WHO cylinder bioas-
says treated with permethrin 0.75%, deltamethrin 0.05% 
and DDT 4%. Comparison was made with the labora-
tory-maintained susceptible An. gambiae Kisumu strain. 
A total of ~100 mosquitoes were exposed in batches of 
25 for 1 h to each insecticide and the control and deaths 
were scored 24 h later.
Experimental hut treatments
The following treatments were tested in the experimental 
huts:
1. Control (untreated net).
2. Interceptor® LN (alpha-cypermethrin—200 mg/sq m 
treated LN).
3. Chlorfenapyr (BASF Phantom 21.45% SC) IRS 
applied at 250 mg/sq m.
4. Chlorfenapyr IRS applied at 250  mg/sq m  +  Inter-
ceptor® LN.
5. Interceptor® G2 LN (chlorfenapyr 200  mg/sq 
m + alpha-cypermethrin 100 mg/sq m mixture LN).
Chlorfenapyr IRS was applied using a Hudson Xpert 
compression sprayer equipped with a 8002 flat fan noz-
zle. The palm thatch used on the ceiling of the hut was 
sprayed lying flat on the floor (outside the hut) and 
allowed to air dry for 1–2  h before being fitted to the 
ceiling of the hut. To estimate the quality of the spray 
applications, the insecticide solution left in the spray 
tank after spraying each hut was poured into a measur-
ing cylinder to determine the volume sprayed. The actual 
sprayed volume was within 10% of the target insecticide 
volume required for each of the chlorfenapyr IRS treated 
huts, suggesting that the spraying was accurate.
All mosquito nets used in the study were unwashed. 
To simulate wear and tear during field use, the nets were 
intentionally holed with 6 holes of area 16 sq cm (2 holes 
on each side and 1 hole on each end) following WHO 
guidelines [17]. To reduce bias due to hut position, the 
mosquito nets were rotated between the respective net 
treatments arms on a weekly basis. Three nets were pre-
pared per treatment arm and these nets were rotated 
every 2 days within each week of the trial.
Trial procedure
The trial ran for 54 nights between June and September 
of 2015. Human volunteer sleepers slept in the huts from 
21:00 to 05:00 each night and were rotated through the 
huts daily to account for individual attractiveness to mos-
quitoes. At dawn, the volunteer sleepers collected dead 
mosquitoes in the room of the hut and under the bed 
nets and all mosquitoes that escaped into the veranda, 
using torches and aspirators. The mosquitoes were then 
transferred to the laboratory for processing where they 
were identified and scored for their blood-feeding sta-
tus, mortality and hut position. Delayed mortality was 
recorded every 24 h up to 72 h, to account for the slow-
acting effect of chlorfenapyr. Mosquitoes were held at 
25 ± 2 °C during the observations.
Outcome measures
The following outcome measures were used to assess the 
efficacy of the treatments in the experimental huts:
1. Deterrence: the proportional reduction in number 
of mosquitoes entering treated huts compared to the 
control hut.
2. Insecticide-induced exiting rates estimated from the 
proportions of mosquitoes collected from the veran-
das of treatment and control huts.
3. Mortality: the proportion of mosquitoes killed 
(immediate plus delayed) relative to the total col-
lected.
4. Blood-feeding inhibition: the proportional reduction 
in blood feeding in huts with insecticide treatments 
relative to the untreated control.
5. Personal protection: the reduction in mosquito biting 
by LNs relative to untreated nets, as derived from the 
formula.
 
where  Bu is the total number of blood-fed mosquitoes 
in the hut with the control, and  Bt is the total number 
blood fed in the huts with treatment.
6. The overall killing effect of a treatment relative to the 
number of mosquitoes that would ordinarily enter an 
untreated control hut was estimated by using the fol-
lowing formula and expressed as a percentage:
 
where  Kt is the number killed in the treated hut,  Ku is 
the number dying in the untreated control hut, and  Tu 
is the total number collected from the control hut.
Tunnel tests
To help explain the findings in the experimental huts, 
tunnel tests were performed with net samples of Inter-
ceptor LN G2 and Interceptor LN using F1 adult mos-
quitoes of the pyrethroid-resistant An. gambiae s.l. 
population from Cove. Comparison was made to a con-
trol net sample. Two-hundred 5–8  days old F1 female 
% personal protection = 100
(Bu − Bt)
Bu
Overall killing effect (%) = 100 (Kt−Ku)/Tu
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mosquitoes were exposed to each netting sample in 2 
replicate tunnels. The tunnel test consists of a square 
glass cylinder (25 cm high, 25 cm wide, 60 cm in length) 
divided into two sections by means of a netting frame fit-
ted into a slot across the tunnel. In one of the sections, a 
guinea pig was housed unconstrained in a small cage, and 
in the other Section  50 unfed female mosquitoes aged 
5–8  days were released at dusk and left overnight. The 
net samples were deliberately holed with nine 1-cm holes 
to give opportunity for mosquitoes to penetrate into the 
animal-baited chamber for a blood meal; an untreated 
net sample served as the control. The tunnels were kept 
overnight in a dark room at 25–27 °C and 75–85% rela-
tive humidity. The next morning, the numbers of mos-
quitoes found alive or dead, fed or unfed, in each section 
were scored. Live mosquitoes were provided with 10% 
glucose solution and delayed mortality recorded after 
72 h.
Data analysis
Proportional outcomes (blood feeding, exiting and mor-
tality) related to each experimental hut treatment were 
assessed using binomial generalized linear mixed mod-
els (GLMMs) with a logit link function, fitted using the 
‘lme4’ package for R (version 2.15.0). A separate model 
was fitted for each outcome. In addition to the fixed effect 
of each treatment, each model included random effects 
to account for the following sources of variation: between 
the huts, between the sleepers, between the weeks of the 
trial, and finally, an observation-level random effect to 
account for variation not explained by the other terms in 
the model (overdispersion).
Differences in deterrence, overall killing effect and per-
sonal protection between the treatments were analysed 
using negative binomial regression based on numbers 
entering and numbers blood fed and killed, respectively, 
with adjustment for the abovementioned covariates.
Results
The WHO susceptibility tests performed on F1 adults An. 
gambiae s.l. mosquitoes collected as larvae from breeding 
sites near in the experimental hut station in Cove showed 
high survival rates (>90%) after exposure to pyrethroids 
(permethrin 0.75% and deltamethrin 0.05%) and organo-
chlorine DDT-treated papers thus confirming the high 
levels of resistance in the Cove vector population to these 
insecticides. Mortality with the susceptible An. gambiae 
Kisumu strain was 100% with all three insecticides. No 
mortality was recorded in the control. Detailed results 
on the susceptibility bioassays are provided in Additional 
file 1: Table S1.
Experimental hut trial results
The experimental hut trial results are presented in 
Tables 1, 2, 3 and Fig. 1. A total of 1153 female An. gam-
biae s.l. were collected in the experimental huts dur-
ing the trial. Deterrency with  Interceptor® LN (44%) 
was higher than with  Interceptor® G2 LN (19%) and 
this did not change significantly compared to the com-
bined chlorfenapyr IRS and  Interceptor® LN hut (49%). 
Table 1 Entry rates of wild An. gambiae sl in experimental huts in Cove, Benin
Control  
(untreated net)
Interceptor® LN Chlorfenapyr  
IRS
Chlorfenapyr IRS + 
 Interceptor® LN
Interceptor® G2 LN
Total females caught 310 175 259 158 251
Average catch per night 5.7 3.2 4.8 2.9 4.6
% deterrence – 44 16 49 19
Table 2 Blood feeding rates of  wild pyrethroid resistant An gambiae sl and  personal protection in  experimental huts 
in Cove, Benin
* Values in the same row sharing a letter superscript do not differ significantly (P > 0.05, GLMM)
Control  
(untreated net)
Interceptor® LN Chlorfenapyr  
IRS
Chlorfenapyr IRS +  
Interceptor® LN
Interceptor® G2 LN
Total blood fed 210 65 209 66 120
% blood fed* 68a 37b 81c 42bd 48d
95% conf. interval 62–73 30–44 76–85 34–50 42–54
% blood-feeding inhibition – 46 – 38 30
% inside net* 52a 26b – 27b 32b
95% conf. interval 46–58 22–30 – 20–34 26–38
% personal protection – 69 0 69 43
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Chlorfenapyr IRS alone induced 16% deterrence, how-
ever, because the IRS treatments could not be all rotated 
between the huts, it was not possible to attribute this 
effect entirely to the treatment.
Blood feeding and personal protection
The results on blood feeding and personal protection 
are presented on Table  2. Blood-feeding rates with the 
control (untreated net) was 68%. Blood-feeding rates 
were lower with  Interceptor® LN compared to the con-
trol (68 vs 37%, P < 0.001) but did not differ significantly 
from the combined chlorfenapyr IRS and  Interceptor® 
LN treatment (37 vs 42% P = 0.396). The proportions fed 
in the huts with  Interceptor® G2 LN (48%) and the com-
bined chlorfenapyr IRS and  Interceptor® LN treatment 
(42%) were also similar (P = 0.236). As expected with IRS 
treatments, blood-feeding rates were very high with chlo-
rfenapyr IRS alone (81%), hence there was no evidence 
of blood-feeding inhibition (Fig.  1) or personal protec-
tion (Table 2) with this treatment. Blood-feeding inhibi-
tion and personal protection with  Interceptor® LN alone 
were 46 and 69%, respectively, and this did not change 
when the net was combined with chlorfenapyr IRS (38 
and 69%, respectively, P > 0.05).  Interceptor® G2 LN also 
Table 3 Overall killing effect of wild pyrethroid resistant An gambiae sl in experimental huts in Cove, Benin
* Values in the same row sharing a letter superscript do not differ significantly (P > 0.05, GLMM)
Control  
(untreated net)
Interceptor® LN Chlorfenapyr  
IRS
Chlorfenapyr IRS +  
Interceptor® LN
Interceptor® G2 LN
N dead after 24 h 8 20 92 57 137
N dead after 72 h 16 45 153 112 185
% corrected 24 h Mortality* 0 8a 34b 34b 54c
% corrected 72 h Mortality* 0 22a 57b 70c 73c
95% conf. interval – 16–24 53–60 67–73 70–77
% overall killing effect – 9 44 31 55
Fig. 1 Mortality (%) and blood-feeding inhibition (%) of pyrethroid-resistant Anopheles gambiae in experimental huts in Cove, Benin. The blue bars 
represent mortality rates while the orange bars represent blood-feeding inhibition rates relative to the control. Bars of the same colour bearing the 
same letter label are not significantly different at the 5% level (P < 0.05, GLMM). Error bars represents 95% CIs.  Interceptor® G2 LN is a new mixture LN 
treated with chlorfenapyr and alpha-cypermethrin while  Interceptor® LN is a standard approved LN treated only with alpha-cypermethrin
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provided substantial levels of blood-feeidng inhibition 
and personal protection (30 and 43%, respectively) but 
these were lower than was observed with  Interceptor® 
LN and the combined intervention. Significantly smaller 
proportions of mosquitoes were also collected inside 
 Interceptor® LN (26–27%) and  Interceptor® G2 LN (32%) 
compared to the control (52%, P < 0.001).
Mortality rates
Mortality results are presented in Table  3 and Fig.  1. 
Mortality rate with the control was 5%. Mortality with 
 Interceptor® LN was 24%. Mortality was higher with 
chlorfenapyr IRS alone (59%) than  Interceptor® LN 
(P < 0.001), but significantly lower compared to the com-
bined chlorfenapyr IRS and  Interceptor® LN intervention 
(59 vs 73%, P = 0.041) (Fig. 1). The highest mortality was 
achieved with  Interceptor® G2 LN (76%) but this did not 
differ significantly from the combined chlorfenapyr IRS 
(76 vs 73%, P = 0.15). Overall killing effect was very low 
with  Interceptor® LN (9%) (Table  3).  Interceptor® G2 
LN induced the highest overall killing effect (55%) com-
pared to chlorfenapyr IRS alone (44%) and the combined 
chlorfenapyr IRS and  Interceptor® LN treatment (31%) 
(P < 0.05).
Tunnel tests results
The tunnel test results with pyrethroid-resistant An. 
gambiae s.l. from Cove are presented in Fig. 2. The trend 
was similar to that observed in the experimental hut 
trial;  Interceptor® G2 LN out-performed Interceptor LN. 
Mortality in the tunnel tests was 1% with the control net 
and 46% with  Interceptor® LN. Mortality was signifi-
cantly higher with  Interceptor® G2 LN (79%, P  <  0.05). 
Blood feeding in the control was 92%. Blood feeding was 
much lower with Interceptor LN (26%) and  Interceptor® 
G2 LN (34%) but did not differ significantly between both 
LN types (P > 0.05). As observed in the hut trial, although 
blood-feeding inhibition in tunnels with  Interceptor® G2 
LN was substantial (63%), it was lower than was achieved 
with  Interceptor® LN (72%).
Discussion
The purpose of this study was to assess the efficacy of 
deploying a combination of unrelated insecticides against 
pyrethroid-resistant populations of malaria vectors either 
as a mixture on LNs or as a combined non-pyrethroid 
IRS and pyrethroid LN intervention.  Interceptor® G2 
LN, a newly developed LN treated with a mixture of 
chlorfenapyr and alphacypermethrin was compared to a 
combined chlorfenapyr IRS and pyrethroid LN interven-
tion in experimental huts in a pyrethroid-resistant area in 
Southern Benin. The low mortality rates (24%) achieved 
with the  Interceptor® LN (pyrethroid-only LN) is very 
typical of most experimental hut studies in pyrethroid-
resistant areas [11, 18, 19]. However, Interceptor LN also 
induced substantial blood-feeding inhibition rates and 
personal protection demonstrating that the pyrethroid 
treatment on the net continues to provide some protec-
tion to the user against this high pyrethroid-resistant 
vector population.
Fig. 2 Mortality (%) and blood-feeding rates (%) of F1 adults of pyrethroid-resistant Anopheles gambiae s.l. from Cove in WHO tunnel tests. The dark 
shade bars represent mortality rates while the lighter shade bars represent blood-feeding rates. Bars of the same colour bearing the same letter label are 
not significantly different at the 5% level. Error bars represents 95% CIs.  Interceptor® G2 LN out-performed  Interceptor® LN in the tunnel tests
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By presenting two unrelated insecticides (alphacyper-
methrin and chlorfenapyr) to the vector population at the 
same time, whether as a combined chlorfenapyr IRS and 
alpha-cypermethrin LN approach or as a mixture on a 
net  (Interceptor® G2 LN), it was possible to significantly 
improve vector mortality and provide personal protec-
tion to the sleeper at the same time. Improved mortality 
was due to the chlorfenapyr component while personal 
protection was mostly due to the excito-repellent effect 
of pyrethroid. These mixture/combination approaches 
therefore show potential to restore malaria vector con-
trol in areas where the efficacy of pyrethroid LNs is being 
compromised by high pyrethroid resistance, to levels 
achievable with susceptible vector populations [20].
Although the mortality rates observed with both mix-
ture/combination strategies were similar, the mixture net 
induced higher levels of overall killing effect while the 
combined intervention provided higher levels of personal 
protection. The latter was probably due to the higher 
concentration of alphacypermethrin in Interceptor LN 
compared to  Interceptor® G2 LN. Overall, the results 
revealed that the combined intervention and mixture net 
approaches are broadly comparable in their impact on 
pyrethroid-resistant malaria vector populations under 
field situations.
Of all the mixture-based strategies recommended 
by the GPIRM for mitigating insecticide resistance in 
malaria vectors, the combined use of non-pyrethroid 
IRS and pyrethroid LNs together has been more widely 
implemented [7, 10, 21, 22]. While some community ran-
domized trials have failed to clearly demonstrate added 
protection with the combined intervention approach 
[21], probably due to issues related to study design, mod-
elling studies have shown that improved impact is pos-
sible but may depend on several factors, including the 
type of IRS insecticide used, the residual efficacy of the 
IRS, the level of resistance in the targeted vector popula-
tion, and the behaviour of the local vector species [22]. 
The improved levels of mortality and substantial personal 
protection obtained with the combined chlorfenapyr 
IRS and pyrethroid LN approach confirm previous find-
ings [11] and demonstrate that chlorfenapyr could be a 
suitable IRS insecticide to complement pyrethroid LNs 
in high pyrethroid-resistant areas with existing high 
pyrethroid LN coverage. The residual protective excito-
repellent effect of the pyrethroid-only net  (Interceptor® 
LN) against the wild pyrethroid-resistant malaria vectors 
was not confounded by the chlorfenapyr IRS treatment 
on the wall when combined. Improved mortality in the 
combined intervention compared to the chlorfenapyr IRS 
alone or pyrethroid LN alone may be due to the to-and-
fro movement of frustrated unfed mosquitoes between 
the LN and the treated wall leading to increased pick 
up of insecticide. It could also be simply due to an addi-
tive effect of the active ingredients in both interventions 
when applied together. Studies evaluating the impact of 
combining chlorfenapyr IRS with pyrethroid LNs on 
malaria in community randomized trials in village clus-
ters are also necessary.
Compared to IRS interventions, which usually require 
complex operational delivery systems, LNs are much 
easier to deliver even in the most remote communities. 
While the use of two active ingredients on a bed net will 
probably increase the total cost of manufacturing of the 
mixture LNs compared to the pyrethroid-only net, the 
operational resources required to deploy the mixture LN 
alone could be less demanding for control programmes 
in endemic resource-limited settings than deploying IRS 
and LNs together.  Interceptor® G2 LN could therefore 
be a more convenient and scalable vector control tool for 
control programmes in resource-limited settings that are 
faced with high pyrethroid resistance compared to the 
combined intervention approach.
Current criteria for efficacy claims of such novel mix-
ture nets defined by the Vector Control Advisory Group 
(VCAG) of the WHO stipulate that the nets should 
induce >25% increase in mortality compared to a stand-
ard pyrethroid net against a vector population with 
>10-fold pyrethroid resistance compared to a suitable 
susceptible strain [23]. By outperforming Interceptor® 
LN with a 65% increase in mortality against the Cove vec-
tor population, which demonstrates >200-fold pyrethroid 
resistance [15], Interceptor® G2 LN therefore meets 
WHO criteria for efficacy against pyrethroid-resistant 
malaria vectors. These findings confirm results from 
recent studies with Interceptor® G2 LN which also dem-
onstrated significantly improved mortality of pyrethroid-
resistant malaria vectors compared to Interceptor® LN 
[24]. Further studies investigating the added impact of 
Interceptor® G2 LN on malaria control in community 
randomized trials in pyrethroid-resistant areas need to 
be performed.
Although improved vector control was achieved with 
the mixture net and combined intervention approach, 
one rationale for such strategies is to manage resistance 
by preventing further selection of insecticide-resistant 
genotypes. Resistance management potential should 
ideally be assessed in more complex, carefully designed, 
community randomized trials which study the impact 
of the interventions on resistance gene frequencies 
over time. Based on modelling studies, the mixture net 
and combined intervention strategies if applied in areas 
with low pyrethroid resistance could delay the emer-
gence of resistance to chlorfenapyr, thus increasing 
the useful life of the insecticide [6]; a hypothesis worth 
investigating.
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Conclusions
Interceptor® G2 LN, a mixture net treated with alpha-
cypermethrin and chlorfenapyr and the combined use of 
chlorfenapyr IRS and  Interceptor® LN provided compa-
rable levels of improved control of pyrethroid-resistant 
malaria vectors. Given that  Interceptor® G2 LN is long 
lasting and much easier to deploy, the mixture net could 
be a more reliable and scale-able means for improving 
the control of pyrethroid-resistant malaria vectors com-
pared to the combined intervention approach. Further 
studies comparing the added impact on malaria control, 
cost-effectiveness and resistance management potential 
of these two strategies in community randomized trials 
are necessary.
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